0. DOCID:10789 SCORE: 0.0040482053549386
DOCNO: 3879860
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: mortality
AUTHOR: F La Rosa F
AUTHOR: A Cresci A
AUTHOR: C Orpianesi C
AUTHOR: G Saltalamacchia G
PUBTYPE: Journal Article
JOURNALTITLE: European journal of epidemiology.
COUNTRY: ITALY
TITLE: Mortality from prostate cancer in Italy: 1950-1979. Cross-sectional rates and cohort analysis.
PUBDATE: 19850601
This paper studies prostate cancer mortality in Italy from 1950-1979 to evaluate its importance in relation to total cancers, examine the time trend for forecasting future mortality trends, and makes an attempt to interpretate mortality by analyzing demographic and risk factors. In the Authors' opinion findings from cross-sectional rates, cohort analysis and Devesa-Schneiderman method, indicate that in Italy even if the age-adjusted mortality rate has nearly doubled over the period, as in many other countries, mortality can be expected to remain constant or decrease in the future, since the data to hand show a decreasing trend in some age cohorts.


1. DOCID:11182 SCORE: 0.00386793194672431
DOCNO: 6982042
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: analysis
QUALIFIER: analysis
QUALIFIER: analysis
QUALIFIER: immunology
AUTHOR: K Ikuta K
AUTHOR: Y Nishi Y
AUTHOR: Y Shimizu Y
AUTHOR: H Higashi H
AUTHOR: N Kitamoto N
AUTHOR: S Kato S
AUTHOR: M Fujita M
AUTHOR: Y Nakano Y
AUTHOR: T Taguchi T
AUTHOR: M Naiki M
PUBTYPE: Journal Article
JOURNALTITLE: Biken journal.
COUNTRY: JAPAN
TITLE: Hanganutziu-Deicher type-heterophile antigen-positive cells in human cancer tissues demonstrated by membrane immunofluorescence.
PUBDATE: 19820301
The possible expression of Hanganutziu-Deicher (H-D)-type heterophile antigen on the cell surface of several types of human cancer tissues was investigated by the membrane immunofluorescence test with anti-H-D serum. Anti-H-D serum of high titer was obtained from chickens immunized with H-D antigen-active glycosphingolipid, N-glycolylneuraminyl-lactosylceramide (equine hematoside). H-D antigen was demonstrated in 3 to 6 gastric cancer tissues, 2 of 3 lung cancer tissues, and 2 of 4 breast tissues examined, but not in 5 colorectal cancer tissues examined.


2. DOCID:10101 SCORE: 0.00332267811119515
DOCNO: 6371436
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: radiotherapy
QUALIFIER: physiopathology
QUALIFIER: physiopathology
AUTHOR: T P Iakimova TP
AUTHOR: I N Lozinskaia IN
PUBTYPE: Journal Article
JOURNALTITLE: Meditsinskaia radiologiia.
COUNTRY: USSR
TITLE: [Thyroid and hypophyseal function during radiation therapy of breast cancer]
PUBDATE: 19840401
In breast cancer a decrease in triiodothyronine concentration was revealed with the normal level of thyroxine that may be associated with the disturbed peripheral metabolism into triiodothyronine. The lowering of thyroid functional activity is noted during radiation therapy of patients at menopause. Administration of thyroidin during radiation therapy to elderly patients with the III stage of the disease compensated for hormone deficiency producing a sparing effect on the thyroid, and influenced the therapeutic results favorably. A high level of the somatotropic hormone was observed in patients of the reproductive age and at menopause, the level of insulin was increased in all the patients.


3. DOCID:9130 SCORE: 0.00276193752163365
DOCNO: 4036740
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: pathology
QUALIFIER: pathology
QUALIFIER: pathology
AUTHOR: T Yamamoto T
AUTHOR: K Nakamura K
AUTHOR: M Shiramizu M
AUTHOR: S Kimura S
AUTHOR: N Kuribayashi N
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Hinyokika kiyo. Acta urologica Japonica.
COUNTRY: JAPAN
TITLE: [Transitional cell carcinoma of the renal pelvis with various histological appearances: a case report]
PUBDATE: 19850401
A large left renal mass was removed from an 85-year-old male. Histological examination revealed various features: Anaplastic transitional cell carcinoma and glandular formation scattered with portions resembling cancer pearls. Sarcomatoid-like area at ureteral margin of the mass and carcinoma-in-situ at renal pelvic mucosa were also seen. Final interpretation was grade III, transitional cell carcinoma, with squamous and glandular differentiation, spindling, and pleomorphic areas.


4. DOCID:11838 SCORE: 0.00270395120737982
DOCNO: 6426894
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Colectomy
DESCRIPTOR: Enteral Nutrition
AUTHOR: B Pasurka B
AUTHOR: D Filler D
AUTHOR: M Kahle M
PUBTYPE: Journal Article
JOURNALTITLE: Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen.
COUNTRY: GERMANY, WEST
TITLE: [Enteral feeding following resection of the colon]
PUBDATE: 19840401
14 male patients with cancer of the colon were enterally fed for 2 days preoperatively, on the day of the operation and 5 days postoperatively with a high-caloric oligopeptide diet without the additional enteral administration of calories. All the anastomoses (5 rectal and 5 sigmoid colon resections as well as 4 hemicolectomies ) healed without problems; no complications occurred . The nutrition was well tolerated without exception and the jejunal tube tolerated without discomfort. The short-lived function proteins fell during postoperative metabolism. However, the means for total protein, albumin, prealbumin, transferrin and the immunoglobulins (IgM, IgG, IgA und IgD) were still within the lower part of the normal range. Only retinol-binding protein fell to values up to 30% below normal.


5. DOCID:10099 SCORE: 0.00269780454063989
DOCNO: 6469159
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
AUTHOR: H O Klein HO
PUBTYPE: Journal Article
JOURNALTITLE: Fortschritte der Medizin.
COUNTRY: GERMANY, EAST
TITLE: [Definite indications for chemotherapy of solid tumors?]
PUBDATE: 19840601
Thirteen human malignant tumors can be cured in a high percentage by combined modality treatment (surgery, radiotherapy, chemotherapy) even if patients suffer from advanced disease. In other neoplasms accounting for about 40% of all tumors, intensive treatment leads to good palliation and significant prolongation of survival time. An important prerequisite for this success is a comprehensive pretherapeutic diagnostic work-up that reveals the extent of disease. Side effects after intensive therapy cannot be completely avoided, but can be alleviated. The complex interrelationship of interdisciplinary therapeutic measures in the context of combination modality treatment makes it necessary that patients with potentially curable neoplasms be treated at cancer centres.


6. DOCID:10636 SCORE: 0.00262306174994515
DOCNO: 6412029
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: blood
AUTHOR: A V Kashkadamov AV
AUTHOR: I V Komissarenko IV
PUBTYPE: Journal Article
JOURNALTITLE: Meditsinskaia radiologiia.
COUNTRY: USSR
TITLE: [Radioimmunoassay in the diagnosis of thyroid cancer]
PUBDATE: 19830801
The paper is concerned with a study of the concentration of thyrotropic hormone (TTH), thyroxine, triidothyronine, thyroxine-binding globulin (TBG), thyroglobulin (TG) and carcinoembryonic antigen (CEA) in the blood of 69 patients with benign and malignant thyroid tumors. It has been established that the determination of TTH and TBG level can be used as an additional criterion to define the nature of a tumor process in the thyroid gland. A study of TTH and TG levels is of diagnostic importance in patients with recurrences and metastases of thyroidal cancer to the lungs. A study of the level of CEA in the blood is an important parameter in the control over the efficacy of thyroid cancer treatment.


7. DOCID:11425 SCORE: 0.00259884806670539
DOCNO: 3834349
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: epidemiology
AUTHOR: B E Henderson BE
AUTHOR: L N Kolonel LN
AUTHOR: R Dworsky R
AUTHOR: D Kerford D
AUTHOR: E Mori E
AUTHOR: K Singh K
AUTHOR: H Thevenot H
PUBTYPE: Journal Article
JOURNALTITLE: National Cancer Institute monograph.
COUNTRY: UNITED STATES
TITLE: Cancer incidence in the islands of the Pacific.
PUBDATE: 19851201
The South Pacific Commission Cancer Registry has been operational since 1977, and reasonably complete cancer incidence rates are available for New Caledonia, Fiji, Micronesia, the Cook Islands, and Niue. In addition, less complete reporting is available from American Samoa, Papua New Guinea, and French Polynesia. Cancers of the lung, oral cavity, esophagus, liver, and cervix are potentially preventable but prevalent in many Pacific island countries. Unusually low rates of many cancers were observed in Fiji, the most notable being lung and colon-rectum. Thyroid cancer rates are elevated in some but not all female populations. These and other variations in cancer by site are important areas for further research.


8. DOCID:11921 SCORE: 0.00240621269023896
DOCNO: 6136703
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: genetics
AUTHOR: R Ottman R
AUTHOR: M C Pike MC
AUTHOR: M C King MC
AUTHOR: B E Henderson BE
PUBTYPE: Journal Article
JOURNALTITLE: Lancet.
COUNTRY: ENGLAND
TITLE: Practical guide for estimating risk for familial breast cancer.
PUBDATE: 19830901
Life-table analysis was used to estimate the cumulative risk of breast cancer to various ages for mothers and sisters of breast cancer patients in a population-based series. These cumulative risk estimates were then used to derive a probability of breast cancer diagnosis within each decade between ages 20 and 70 for mothers and sisters, according to age of diagnosis in the patient and whether the disease was unilateral or bilateral. Risks for relatives of premenopausal patients with unilateral disease were no higher than those for relatives of postmenopausal patients. Relatives of premenopausal patients with bilateral disease had higher risk than relatives of patients with unilateral disease, irrespective of age at diagnosis in those with unilateral disease. Sisters were at higher risk than were mothers.


9. DOCID:11888 SCORE: 0.00229470215924671
DOCNO: 6513026
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: pathology
QUALIFIER: pathology
QUALIFIER: pathology
QUALIFIER: pathology
AUTHOR: K Matsumoto K
AUTHOR: Y Sugiyama Y
AUTHOR: K Miyagishima K
AUTHOR: T Murakami T
AUTHOR: N Yamagata N
AUTHOR: H Tsuchida H
AUTHOR: M Sasamura M
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Gan no rinsho. Japan journal of cancer clinics.
COUNTRY: JAPAN
TITLE: [Primary adenosquamous carcinoma of the stomach--a case report]
PUBDATE: 19841001
A 56-year-old man was hospitalized with the complaint of upper abdominal discomfort. A gastrointestinal series revealed a filling defect in the body of the stomach. Under the diagnosis of gastric cancer, total gastrectomy was performed. Borrmann III type cancer measuring 5 X 4 cm, extending to the antrum and the upper portion of the body of the stomach, was identified in the body. Histologically, most of the tumor consisted of squamous cell carcinoma. Adenocarcinoma and a small nest of squamous metaplasia were observed at the peripheral wall of this tumor. The pathological diagnosis was adenosquamous carcinoma. In some regional lymph nodes, metastasis of adenocarcinoma was observed.


10. DOCID:11280 SCORE: 0.00227634822125891
DOCNO: 6747672
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Physician-Patient Relations
DESCRIPTOR: Truth Disclosure
QUALIFIER: psychology
AUTHOR: R J Goldberg RJ
PUBTYPE: Journal Article
JOURNALTITLE: Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
COUNTRY: UNITED STATES
TITLE: Disclosure of information to adult cancer patients: issues and update.
PUBDATE: 19840801
Clinicians are regularly faced with decisions regarding disclosure of information to cancer patients. Many of these decisions constitute a dilemma between the physician's paternalistic concern for the patient and the patient's right to know as much as possible. This paper reviews changes in the attitudes of physicians over the last several decades, elaborates on the problems that confront the clinician in the process of disclosure, and reviews the available data concerning the documented impact on the patient from receiving or not receiving information. The arguments both supporting and challenging the paternalistic view are discussed, and the necessity for viewing the disclosure of clinical information as a clinical process is offered.


11. DOCID:9667 SCORE: 0.00226371599101069
DOCNO: 6439407
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: toxicity
QUALIFIER: chemically induced
QUALIFIER: physiology
QUALIFIER: chemically induced
QUALIFIER: chemically induced
AUTHOR: B Arun B
AUTHOR: M Udayachander M
AUTHOR: A Meenakshi A
PUBTYPE: Journal Article
JOURNALTITLE: Cancer letters.
COUNTRY: NETHERLANDS
TITLE: 7,12-Dimethylbenzanthracene induced mammary tumours in Wistar rats by 'air pouch' technique--a new approach.
PUBDATE: 19841201
An 'air pouch' technique of inducing highly localized, transplantable, estrogen-dependent adenocarcinomas of the mammary gland in Wistar rats with 7,12-dimethylbenzanthracene (DMBA) is described. The induction time was 67-80 days compared to 150-180 days by the conventional technique. Using this model estrogen receptor status, transplantation and effect of exogenous hormones on tumour growth have been studied. It is felt that this model might be a useful one for studying the biochemical mechanisms involved in hormone-dependent experimental mammary cancers.


12. DOCID:8962 SCORE: 0.00225982775894187
DOCNO: 6547325
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: secondary
QUALIFIER: pathology
QUALIFIER: pathology
AUTHOR: T Inoshita T
AUTHOR: A R Laurain AR
AUTHOR: G A Youngberg GA
AUTHOR: G Musil G
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Archives of pathology & laboratory medicine.
COUNTRY: UNITED STATES
TITLE: Metastasis of bronchogenic carcinoma to the skin involved by melanoma.
PUBDATE: 19840701
In a 52-year-old man, a cutaneous malignant melanoma developed concurrently with an adenocarcinoma of the right lung. The latter disseminated widely, and autopsy disclosed that it had also metastasized to the dermal tissue involved with the melanoma. Because it was not a metastasis into the substance of the melanoma, it was classified as an unusual type of "collision tumor" rather than a "cancer-to-cancer" metastasis.


13. DOCID:10397 SCORE: 0.00224714993904096
DOCNO: 4022820
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Cell Transformation, Neoplastic
DESCRIPTOR: DNA, Neoplasm
QUALIFIER: genetics
AUTHOR: B M Sutherland BM
AUTHOR: P V Bennett PV
PUBTYPE: Journal Article
JOURNALTITLE: Photo-dermatology.
COUNTRY: DENMARK
TITLE: Human cell transfection with skin cancer DNAs.
PUBDATE: 19850601
Spectacular progress towards understanding the molecular changes in DNA of many human tumors has been gained using NIH 3T3s as cellular recipients of transfecting DNA (1). Similar advances in analyzing human skin cancers have not been possible, as DNAs of most skin cancers or skin cancer cell lines--including most malignant melanomas--do not transform 3T3s (2). We have developed a DNA transfection system using human cells as recipients (3): normal human cells are transformed to anchorage-independent growth by transfection with a variety of skin cancer DNAs. This method may allow identification of the genes and specific sequences altered in sunlight-induced human skin cancers.


14. DOCID:11755 SCORE: 0.00223495157539028
DOCNO: 6507380
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
AUTHOR: M A Goldsmith MA
AUTHOR: T Ohnuma T
AUTHOR: I H Jaffrey IH
AUTHOR: E M Greenspan EM
AUTHOR: J F Holland JF
PUBTYPE: Journal Article
JOURNALTITLE: American journal of clinical oncology : the official publication of the American Radium Society.
COUNTRY: UNITED STATES
TITLE: Phase I study of mitoxantrone on a daily X 5 schedule.
PUBDATE: 19841001
Mitoxantrone (NSC-301739) is a synthetic amino anthraquinone DNA intercalater active in several experimental tumor systems. Thirty-three patients with advanced cancer received the drug on a daily X 5 schedule. Myelosuppression, especially leukopenia, was the dose-limiting toxicity and was reversible. Nausea and vomiting occurred sporadically. No definite hepatic, renal, or cardiac toxicities were noted. The recommended dose for phase II evaluation in solid tumor patients with little or no prior therapy is 4.2 mg/m2/day X 5. Patients with prior myelosuppressive therapy but adequate bone marrow reserve may be started at 2.6 mg/m2/day X 5.